Edit |   |
---|---|
Antigenic Specificity | CD19 & CD3E, Human (Blinatumomab biosimilar) |
Clone | Blinatumomab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | (scFv kappa-heavy)-(scFv-heavy kappa) |
Format | scFv fragment |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD19 & CD3E Recombinant Antibody (Blinatumomab). Blinatumomab, sold under the brand name Blincyto, is a biopharmaceutical medication used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia. |
Immunogen | n/a |
Other Names | Anti-CD19 & CD3E Recombinant Antibody, Research Grade Blinatumomab, Anti-Human CD19 & CD3E Recombinant Antibody(Blinatumomab), AMG103, BITE MT-103, Antibody Drug Analogues, Monoclonal Antibody, YR1047, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 853426-35-4 |
Catalog # | YR1047 |
Price | please inquire |
Order / More Info | CD19 & CD3E, Human (Blinatumomab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |